Anti-Serine Palmitoyltransferase antibody - C-terminal (ab71631)
- Product nameAnti-Serine Palmitoyltransferase antibody - C-terminalSee all Serine Palmitoyltransferase primary antibodies ...
- DescriptionRabbit polyclonal to Serine Palmitoyltransferase - C-terminal
- Tested applicationsELISA, WB more details
- Species reactivityReacts with: Mouse, Human
Synthetic peptide conjugated to KLH, corresponding to C terminal amino acids 532-562 of Human Serine Palmitoyltransferase
- Positive control
- Mouse liver tissue lysate.
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: 0.09% Sodium Azide
- Concentration information loading...
- PurityProtein G purified
- Purification notesab71631 is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Clonality Polyclonal
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Lipid metabolism
Our Abpromise guarantee covers the use of ab71631 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||WB: 1/100 - 1/500. Detects a band of approximately 62 kDa (predicted molecular weight: 62 kDa).|
- FunctionSerine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SSSPTA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SSSPTB complex displays a preference for C18-CoA substrate.
- Tissue specificityWidely expressed.
- PathwayLipid metabolism; sphingolipid metabolism.
- Involvement in diseaseDefects in SPTLC2 are the cause of hereditary sensory and autonomic neuropathy type 1C (HSAN1C) [MIM:613640]. It is a form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by prominent sensory abnormalities with a variable degree of motor and autonomic dysfunction. The neurological phenotype is often complicated by severe infections, osteomyelitis, and amputations. HSAN1C symptoms include loss of touch and vibration in the feet, dysesthesia and severe panmodal sensory loss in the upper and lower limbs, distal lower limb sensory loss with ulceration and osteomyelitis, and distal muscle weakness.
- Sequence similaritiesBelongs to the class-II pyridoxal-phosphate-dependent aminotransferase family.
- Cellular localizationEndoplasmic reticulum membrane.
- KIAA0526 antibody
- LCB 2 antibody
- LCB2 antibody
- LCB2a antibody
- Long chain base biosynthesis protein 2 antibody
- Long chain base biosynthesis protein 2a antibody
- Serine palmitoyl CoA transferase 2 antibody
- Serine palmitoyltransferase 2 antibody
- Serine palmitoyltransferase long chain base subunit 2 antibody
- Serine palmitoyltransferase subunit II antibody
- Serine-palmitoyl-CoA transferase 2 antibody
- SPT 2 antibody
- SPT2 antibody
- SPTC2_HUMAN antibody
- SPTLC 2 antibody
- SPTLC2 antibody
Anti-Serine Palmitoyltransferase antibody - C-terminal images
Anti-Serine Palmitoyltransferase antibody - C-terminal (ab71631) at 1/100 dilution + mouse liver tissue lysate at 12.5 µg
Predicted band size : 62 kDa
Observed band size : 62 kDa
Additional bands at : 75 kDa. We are unsure as to the identity of these extra bands.
References for Anti-Serine Palmitoyltransferase antibody - C-terminal (ab71631)
ab71631 has not yet been referenced specifically in any publications.